SRTS Key Statistics, Chart & Performance
The current stock price of SRTS is 3.79 USD. In the past month the price decreased by -11.03%. In the past year, price decreased by -47.43%.
SRTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.01 | 217.03B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.03 | 204.60B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.59 | 142.51B | ||
| SYK | STRYKER CORP | 26.94 | 135.66B | ||
| BDX | BECTON DICKINSON AND CO | 13.6 | 55.98B | ||
| IDXX | IDEXX LABORATORIES INC | 54.57 | 54.95B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.58 | 50.07B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.17 | 37.99B | ||
| RMD | RESMED INC | 24.69 | 35.68B | ||
| DXCM | DEXCOM INC | 36.25 | 26.30B | ||
| PODD | INSULET CORP | 63.2 | 20.32B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.15 | 17.88B |
Related stock screener links
About SRTS
Company Profile
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Company Info
SENSUS HEALTHCARE INC
851 Broken Sound Pkwy NW Ste 215
Boca Raton FLORIDA 33487 US
CEO: Joseph C. Sardano
Employees: 35
Phone: 15619225808
SENSUS HEALTHCARE INC / SRTS FAQ
What does SENSUS HEALTHCARE INC do?
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Can you provide the latest stock price for SENSUS HEALTHCARE INC?
The current stock price of SRTS is 3.79 USD.
Does SRTS stock pay dividends?
SRTS does not pay a dividend.
What is the ChartMill rating of SENSUS HEALTHCARE INC stock?
SRTS has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of SENSUS HEALTHCARE INC (SRTS) based on its PE ratio?
SENSUS HEALTHCARE INC (SRTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).
Can you provide the market cap for SENSUS HEALTHCARE INC?
SENSUS HEALTHCARE INC (SRTS) has a market capitalization of 62.27M USD. This makes SRTS a Micro Cap stock.
Can you provide the upcoming earnings date for SENSUS HEALTHCARE INC?
SENSUS HEALTHCARE INC (SRTS) will report earnings on 2026-02-03, after the market close.
SRTS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SRTS. When comparing the yearly performance of all stocks, SRTS is a bad performer in the overall market: 79.69% of all stocks are doing better.
SRTS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SRTS. While SRTS has a great health rating, there are worries on its profitability.
SRTS Financial Highlights
Over the last trailing twelve months SRTS reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -133.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.16% | ||
| ROE | -5.87% | ||
| Debt/Equity | 0 |
SRTS Forecast & Estimates
For the next year, analysts expect an EPS growth of -187.55% and a revenue growth -21.22% for SRTS